91ÖÆƬ³§

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Operation
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oncology Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Oncology
1.3.3 Radiation Oncology
1.3.4 Surgical Oncology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Solution Market Perspective (2018-2029)
2.2 Oncology Solution Growth Trends by Region
2.2.1 Global Oncology Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncology Solution Historic Market Size by Region (2018-2023)
2.2.3 Oncology Solution Forecasted Market Size by Region (2024-2029)
2.3 Oncology Solution Market Dynamics
2.3.1 Oncology Solution Industry Trends
2.3.2 Oncology Solution Market Drivers
2.3.3 Oncology Solution Market Challenges
2.3.4 Oncology Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Solution Players by Revenue
3.1.1 Global Top Oncology Solution Players by Revenue (2018-2023)
3.1.2 Global Oncology Solution Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Solution Revenue
3.4 Global Oncology Solution Market Concentration Ratio
3.4.1 Global Oncology Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Solution Revenue in 2022
3.5 Oncology Solution Key Players Head office and Area Served
3.6 Key Players Oncology Solution Product Solution and Service
3.7 Date of Enter into Oncology Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Solution Breakdown Data by Type
4.1 Global Oncology Solution Historic Market Size by Type (2018-2023)
4.2 Global Oncology Solution Forecasted Market Size by Type (2024-2029)
5 Oncology Solution Breakdown Data by Application
5.1 Global Oncology Solution Historic Market Size by Application (2018-2023)
5.2 Global Oncology Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncology Solution Market Size (2018-2029)
6.2 North America Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncology Solution Market Size by Country (2018-2023)
6.4 North America Oncology Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Solution Market Size (2018-2029)
7.2 Europe Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncology Solution Market Size by Country (2018-2023)
7.4 Europe Oncology Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Solution Market Size (2018-2029)
8.2 Asia-Pacific Oncology Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncology Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Solution Market Size (2018-2029)
9.2 Latin America Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncology Solution Market Size by Country (2018-2023)
9.4 Latin America Oncology Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Solution Market Size (2018-2029)
10.2 Middle East & Africa Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncology Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 The Chartis Group
11.1.1 The Chartis Group Company Detail
11.1.2 The Chartis Group Business Overview
11.1.3 The Chartis Group Oncology Solution Introduction
11.1.4 The Chartis Group Revenue in Oncology Solution Business (2018-2023)
11.1.5 The Chartis Group Recent Development
11.2 McKesson
11.2.1 McKesson Company Detail
11.2.2 McKesson Business Overview
11.2.3 McKesson Oncology Solution Introduction
11.2.4 McKesson Revenue in Oncology Solution Business (2018-2023)
11.2.5 McKesson Recent Development
11.3 Cerner
11.3.1 Cerner Company Detail
11.3.2 Cerner Business Overview
11.3.3 Cerner Oncology Solution Introduction
11.3.4 Cerner Revenue in Oncology Solution Business (2018-2023)
11.3.5 Cerner Recent Development
11.4 BCG
11.4.1 BCG Company Detail
11.4.2 BCG Business Overview
11.4.3 BCG Oncology Solution Introduction
11.4.4 BCG Revenue in Oncology Solution Business (2018-2023)
11.4.5 BCG Recent Development
11.5 Magellan Rx Management
11.5.1 Magellan Rx Management Company Detail
11.5.2 Magellan Rx Management Business Overview
11.5.3 Magellan Rx Management Oncology Solution Introduction
11.5.4 Magellan Rx Management Revenue in Oncology Solution Business (2018-2023)
11.5.5 Magellan Rx Management Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Detail
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Oncology Solution Introduction
11.6.4 Cardinal Health Revenue in Oncology Solution Business (2018-2023)
11.6.5 Cardinal Health Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Oncology Solution Introduction
11.7.4 GE Healthcare Revenue in Oncology Solution Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 Philips Healthcare
11.8.1 Philips Healthcare Company Detail
11.8.2 Philips Healthcare Business Overview
11.8.3 Philips Healthcare Oncology Solution Introduction
11.8.4 Philips Healthcare Revenue in Oncology Solution Business (2018-2023)
11.8.5 Philips Healthcare Recent Development
11.9 eviCore
11.9.1 eviCore Company Detail
11.9.2 eviCore Business Overview
11.9.3 eviCore Oncology Solution Introduction
11.9.4 eviCore Revenue in Oncology Solution Business (2018-2023)
11.9.5 eviCore Recent Development
11.10 Canon Medical Systems
11.10.1 Canon Medical Systems Company Detail
11.10.2 Canon Medical Systems Business Overview
11.10.3 Canon Medical Systems Oncology Solution Introduction
11.10.4 Canon Medical Systems Revenue in Oncology Solution Business (2018-2023)
11.10.5 Canon Medical Systems Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Oncology Solution Introduction
11.11.4 Roche Revenue in Oncology Solution Business (2018-2023)
11.11.5 Roche Recent Development
11.12 GenomOncology
11.12.1 GenomOncology Company Detail
11.12.2 GenomOncology Business Overview
11.12.3 GenomOncology Oncology Solution Introduction
11.12.4 GenomOncology Revenue in Oncology Solution Business (2018-2023)
11.12.5 GenomOncology Recent Development
11.13 B. Braun Medical
11.13.1 B. Braun Medical Company Detail
11.13.2 B. Braun Medical Business Overview
11.13.3 B. Braun Medical Oncology Solution Introduction
11.13.4 B. Braun Medical Revenue in Oncology Solution Business (2018-2023)
11.13.5 B. Braun Medical Recent Development
11.14 Carelon Insights
11.14.1 Carelon Insights Company Detail
11.14.2 Carelon Insights Business Overview
11.14.3 Carelon Insights Oncology Solution Introduction
11.14.4 Carelon Insights Revenue in Oncology Solution Business (2018-2023)
11.14.5 Carelon Insights Recent Development
11.15 Diagnóstica Longwood
11.15.1 Diagnóstica Longwood Company Detail
11.15.2 Diagnóstica Longwood Business Overview
11.15.3 Diagnóstica Longwood Oncology Solution Introduction
11.15.4 Diagnóstica Longwood Revenue in Oncology Solution Business (2018-2023)
11.15.5 Diagnóstica Longwood Recent Development
11.16 Innovative Oncology Solutions
11.16.1 Innovative Oncology Solutions Company Detail
11.16.2 Innovative Oncology Solutions Business Overview
11.16.3 Innovative Oncology Solutions Oncology Solution Introduction
11.16.4 Innovative Oncology Solutions Revenue in Oncology Solution Business (2018-2023)
11.16.5 Innovative Oncology Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details